Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Kura Oncology, Inc. Filed Acc 0000921895-26-003183

Stakes reported in this filing

Reporting person Shares Of the class
BVF PARTNERS L P/IL 6,690,108 7.5%
BVF INC/IL 6,690,108 7.5%
LAMPERT MARK N 6,690,108 7.5%
BVF GP HOLDINGS LLC 6,120,843 6.9%
BIOTECHNOLOGY VALUE FUND L P 3,499,795 3.9%
BVF I GP LLC 3,499,795 3.9%
BIOTECHNOLOGY VALUE FUND II LP 2,621,048 2.9%
BVF II GP LLC 2,621,048 2.9%
Biotechnology Value Trading Fund OS LP 443,395 0.5%
BVF Partners OS Ltd. 443,395 0.5%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…